ZA914435B - Treatment of disease - Google Patents

Treatment of disease

Info

Publication number
ZA914435B
ZA914435B ZA914435A ZA914435A ZA914435B ZA 914435 B ZA914435 B ZA 914435B ZA 914435 A ZA914435 A ZA 914435A ZA 914435 A ZA914435 A ZA 914435A ZA 914435 B ZA914435 B ZA 914435B
Authority
ZA
South Africa
Prior art keywords
disease
treatment
Prior art date
Application number
ZA914435A
Other languages
English (en)
Inventor
James Warren Winkelman
Warren Winkelman James
Blaik Phillip Halling
Phillip Halling Blaik
Debra Ann Witkowski
Ann Witkowski Debra
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of ZA914435B publication Critical patent/ZA914435B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA914435A 1990-06-11 1991-06-10 Treatment of disease ZA914435B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53579490A 1990-06-11 1990-06-11

Publications (1)

Publication Number Publication Date
ZA914435B true ZA914435B (en) 1992-03-25

Family

ID=24135791

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914435A ZA914435B (en) 1990-06-11 1991-06-10 Treatment of disease

Country Status (7)

Country Link
AU (1) AU8185491A (pt)
CS (1) CS176291A3 (pt)
IE (1) IE911971A1 (pt)
IL (1) IL98405A0 (pt)
PT (1) PT97937A (pt)
WO (1) WO1991019418A1 (pt)
ZA (1) ZA914435B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
PL328617A1 (en) * 1996-02-28 1999-02-01 Novartis Ag Promotors of protoporphyrinogen oxidase genes residing in plants
CN103694243B (zh) * 2013-12-20 2015-09-09 中国农业大学 2-取代吡啶基-1,2,4-三唑并[1,2-a]哒嗪化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190371B (en) * 1980-12-18 1986-08-28 The Wellcome Foundation Ltd,Gb Process for producing ether-type compounds and pharmaceutical compositions containing them as active agents
CA1192545A (en) * 1982-02-16 1985-08-27 Glaxo Group Limited Heterocyclic derivatives as histamine h.sub.2- antagonists
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US4820722A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazoles and their use as leukotriene antagonists
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione

Also Published As

Publication number Publication date
AU8185491A (en) 1992-01-07
IL98405A0 (en) 1992-07-15
CS176291A3 (en) 1992-08-12
PT97937A (pt) 1992-04-30
IE911971A1 (en) 1991-12-18
WO1991019418A1 (en) 1991-12-26

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions &amp; diseases
GB9026278D0 (en) Autoimmune disease treatment
GB8928934D0 (en) Treatment of birds
GB2243296B (en) Treatment of disease associated with hiv-infections
AP9100290A0 (en) Pharmaceutical treatment
GB9025710D0 (en) Novel treatment
ZA914435B (en) Treatment of disease
GB9024928D0 (en) Novel treatment
GB9022470D0 (en) Treatment of clays
ZA9189B (en) Treatment of protozoal diseases
GB9216360D0 (en) Treatment of blood
RU1833739C (ru) Cпocoб лeчehия гипepkaлиemии
GB8829366D0 (en) Treatment of disease
GB9024926D0 (en) Novel treatment
GB9024925D0 (en) Novel treatment
GB9021960D0 (en) Treatment of flax
IE901990L (en) Treatment of gut disorders
EG20171A (en) Treatment of conditions and disease
GB9026067D0 (en) Medical treatment
GB9024140D0 (en) Medical treatment
GB9008524D0 (en) Treatment of cancer
GB9005050D0 (en) Treatment of diabetes
GB9026620D0 (en) Treatment of lung diseases
IE900102L (en) Treatment of skin disorders
RU1833736C (en) Means of treatment of psoriasis